Ten healthy volunteers received single 2-mg doses of lorazepam on five occasions in random sequence. Modes of administration were: A, intravenous injection; B, deltoid intramuscular injection; C, oral tablets in the fasting state; D, sublingual dosage of oral tablets in the fasting state; and E, sub
Pharmacokinetics of midazolam: comparison of sublingual and intravenous routes in rabbit
✍ Scribed by P. Odou; C. Barthélémy; D. Chatelier; M. Luyckx; C. Brunet; T. Dine; B. Gressier; M. Cazin; J. C. Cazin; H. Robert
- Publisher
- Springer-Verlag
- Year
- 1999
- Tongue
- English
- Weight
- 797 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0378-7966
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Twelve children 1-5 y old were randomly assigned to receive midazolam 0.2 mg.kg-1 either by the intravenous (IV) or intranasal (IN) routes. After IN administration the rapid onset of absorption was observed (tmax 12 min). After both routes of administration the half-life was similar (2.2 h IN and 2.
The pharmacokinetics of midazolam, a water soluble 1,4-benzodiazepine, has been studied in 12 patients (11 male, 1 female; age range 19-57 years) with epilepsy. All patients were taking hepatic enzyme inducing antiepileptic drugs (AEDs) on a regular basis. Midazolam (5 mg) was administered intraveno
A rabbit model for investigating sublingual drug absorption was established yielding results consistent with clinical data reported in the literature. Using propranolol as a model compound the effect of formulation and dosing variables was explored as a means to characterize the limiting parameters
The systemic bioavailability of the calcium channel blocker verapamil HCl after sublingual (SL) administration has been clinically demonstrated. [1][2][3][4][5] Therefore, this compound was chosen as a model compound for evaluation during establishment of a preclinical rabbit model for intra-oral dr